EN DE
Watch IVIM Technology, Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

IVIM Technology, Inc (460470) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of IVIM Technology, Inc stock KRW 1,197, price KRW 2,155, that is 44.5% below the price, quality 41 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare KR

IT IVIM Technology, Inc logo Thin data Nov 3, 2026

IVIM Technology, Inc

460470 · KQ
Very expensive, weak quality

Our calculation puts a fair price 44% below what the stock costs today.

Low debt
Quality 41/100
Expensive Growth (revenue 3y +48.4 %/yr in KRW)
Fair value 1,197 KRW · Strongly overvalued
Loss-making · -40.9% net margin (TTM)
Negative free cash flow
Trails peers (3/10)
Narrow moat 6/100 · thin data
Thin data
Watch IVIM Technology, Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

13,360 KRW 2,155 KRW Fair Value 1,197 KRW Aug 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

27‑month range 2,155 KRW – 13,360 KRW · fair‑value band 789.71 KRW – 1,496 KRW · the 2,155 KRW price screens above the 1,197 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow IVIM Technology in your weekly email

Every Wednesday you see whether IVIM Technology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

IVIM Technology, Inc. develops intravital microscopy (IVM) platform.

Show moreShow less

Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products.

The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications.

The company was founded in 2017 and is based in Daejeon, South Korea.

Stock analysis

IVIM Technology, Inc (460470) currently trades at 2,155 KRW, while our model-based Fair Value estimate is 1,197 KRW, 44% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the data coverage at low.

Scenario range: 789.71 KRW (bear) to 1,496 KRW (bull), the price of 2,155 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

IVIM Technology, Inc reported revenue of 4.4B KRW in FY2025 versus 527M KRW in FY2021, a compound +69.8%/yr. Reported net income was −3.8B KRW in FY2025.

Key figures

Market cap 32.7B KRW (≈ $24.2M) Micro · P/S ratio 5.73 · EPS (TTM) −177.37 KRW · Net margin −40.9% · Return on equity −9.8% · Return on assets (EBIT) −19.9% (5-year average) · Operating margin −6.6% · Revenue (TTM) 6.6B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 55% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at −44%, 460470 screens richer than that median.

Fair Value models

Bear 789.71 KRW Fair Value 1,197 KRW Bull 1,496 KRW
Price 2,155 KRW · Downside -44.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) 789.71 KRW 1,197 KRW 1,496 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 789.71 KRW 1,197 KRW 1,496 KRW 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 41/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 2
How much profit the company makes from its sales and capital
Quality Growth 61
Are margins and returns getting better?
Cashflow 14
Do the profits arrive as real cash?
Financial strength 83
Debt, balance sheet and risk of trouble
Investment 9
Does it invest with discipline instead of growing at any price?
Low Volatility 37
How calm the share price moves, does not count
Price momentum 13
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 80
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+22.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+48.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−504.5% (2021) → −94.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

460470 screens overvalued: fair value 44% below the price. Compare with Abbott Laboratories, →

Compare IVIM Technology, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 319 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside −44.5% · Below median
Profitability
Return on assets −12.6% · Bottom 25%
Net margin (12 months) −40.9% · Bottom 25%
Operating margin (12 months) −6.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 312.6% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 1.18× · Cheaper than median
P/S (12 months) 4.99× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)100 · sector 36
PAST (return on equity)0 · sector 17
HEALTH (low debt)99 · sector 98
DIVIDEND (yield)0 · sector 34

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥181.10 ¥202.57 +12% vs 460470
Stryker Corporation SYK $325.87 $358.46 +10% vs 460470
Boston Scientific Corporation BSX $42.75 $47.03 +10% vs 460470
DexCom, Inc DXCM $79.41 $87.35 +10% vs 460470
GE HealthCare Technologies Inc GEHC $82.38 $69.92 −15% vs 460470
Edwards Lifesciences Corporation EW $102.14 $81.94 −20% vs 460470
Siemens Healthineers AG SHL €43.16 €34.51 −20% vs 460470
Abbott Laboratories, ABT $109.93 $75.28 −32% vs 460470
Medtronic plc MDT $101.80 $65.61 −36% vs 460470
Koninklijke Philips N.V PHIA €27.30 €15.23 −44% vs 460470

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

IVIM Technology, Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "IVIM Technology, Inc Fair Value". https://www.fairvalue-calculator.com/stock/460470

Frequently asked questions

Is IVIM Technology, Inc (460470) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 1,197 KRW versus a price of 2,155 KRW, about 44% lower (overvalued).
What is the fair value of 460470?
Our model-based fair value for IVIM Technology, Inc is 1,197 KRW (as of Nov 3, 2026), built from audited fundamentals. The current price: 2,155 KRW.
What is the quality score of 460470?
IVIM Technology, Inc has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for IVIM Technology, Inc (460470)?
Our model-based price target is the fair value of 1,197 KRW (as of Nov 3, 2026) from 1 valuation models. Cautious scenario 789.71 KRW, optimistic scenario 1,496 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the IVIM Technology, Inc stock forecast for 2026?
Our models put fair value at 1,197 KRW, about 44% lower versus a price of 2,155 KRW (overvalued). Cautious scenario 789.71 KRW, optimistic scenario 1,496 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of IVIM Technology, Inc (460470)?
IVIM Technology, Inc reported trailing-twelve-month revenue of about 6.6B KRW (latest available figure, as of Nov 3, 2026).
What is the intrinsic value of IVIM Technology, Inc (460470)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For IVIM Technology, Inc it is 1,197 KRW per share (as of Nov 3, 2026), against a price of 2,155 KRW. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is IVIM Technology, Inc stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 460470 trades above its calculated fair value: price 2,155 KRW, fair value 1,197 KRW, a gap of about −44% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 460470?
No. The price is what the market pays today (2,155 KRW); the fair value is what the company's own numbers justify (1,197 KRW). For IVIM Technology, Inc the two are 958.47 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is IVIM Technology, Inc worth?
The market values IVIM Technology, Inc at about 32.7B KRW (market capitalisation, as of Nov 3, 2026). Per share that is 2,155 KRW; our models calculate a fair value of 1,197 KRW per share.
What do the bullish and bearish scenarios say about 460470?
Our models span a range for IVIM Technology, Inc: cautious scenario 789.71 KRW, base 1,197 KRW, optimistic 1,496 KRW per share (as of Nov 3, 2026, price 2,155 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of IVIM Technology, Inc (460470)?
Balance-sheet figures for IVIM Technology, Inc (as of Nov 3, 2026): return on equity −9.8%, debt of 0.03 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is 460470 from its 52-week high?
IVIM Technology, Inc trades at 2,155 KRW, about 55% below its 52-week high of 4,745 KRW and at the low of 2,155 KRW (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 1,197 KRW is for.
Which stocks are comparable to IVIM Technology, Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is IVIM Technology, Inc stock attractive at the current price?
The data as of Nov 3, 2026: price 2,155 KRW, calculated fair value 1,197 KRW (−44%), Quality Score 41/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 460470 calculated?
We run IVIM Technology, Inc through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of 1,197 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. IVIM Technology, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of IVIM Technology, Inc (460470)?
The closing price on Nov 9, 2026 was 2,155 KRW. Our model-based fair value is 1,197 KRW, about 44% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with IVIM Technology, Inc right now?
The price sits above even our optimistic bull case (1,496 KRW). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (789.71 KRW to 1,496 KRW) leaves room in how you read the outcome.

Key figures of IVIM Technology, Inc

How large is the market capitalisation of IVIM Technology, Inc (460470)?
The market capitalisation of IVIM Technology, Inc is 32.7B KRW (≈ $24.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of IVIM Technology, Inc (460470)?
The price-to-sales ratio of IVIM Technology, Inc is 5.73 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of IVIM Technology, Inc (460470)?
Earnings per share at IVIM Technology, Inc are −177.37 KRW. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of IVIM Technology, Inc (460470)?
The net margin of IVIM Technology, Inc is −40.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of IVIM Technology, Inc (460470)?
The return on equity (ROE) of IVIM Technology, Inc is −9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of IVIM Technology, Inc (460470)?
On an EBIT basis the return on assets of IVIM Technology, Inc is −19.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of IVIM Technology, Inc (460470)?
The operating margin of IVIM Technology, Inc is −6.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at IVIM Technology, Inc (460470)?
Revenue at IVIM Technology, Inc is growing +313% versus a year earlier (3y avg +48.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does IVIM Technology, Inc (460470) generate?
The free cash flow of IVIM Technology, Inc is −6.7B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does IVIM Technology, Inc (460470) carry?
The net debt of IVIM Technology, Inc is 507M KRW (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch IVIM Technology, Inc in the live analysis

One click puts IVIM Technology, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.